Priority Setting Partnership aimed to identify and prioritise unanswered questions important to adult patients, their families and health professionals with lived experience of critical care across ...
Detailed price information for Select Medical Holdings Corp (SEM-N) from The Globe and Mail including charting and trades.
Select Medical Holdings Corporation (NYSE:SEM) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good morning, and thank you for joining us today for Select Medical Holdings Corporation ...
Two hospitals shared plans to close the week of Feb. 16, highlighting the mounting financial and operational challenges that many healthcare facilities face across the country. Regency ...
Shares of Select Medical Holdings fell after the company's fourth-quarter earnings disappointed Wall Street analysts despite swinging to a profit. Shares were down 6.1% to $15.10 in Friday afternoon ...
Detailed price information for Select Medical Holdings Corp (SEM-N) from The Globe and Mail including charting and trades.
Q4 2025 earnings call recap: 2026 guidance, rehab bed expansion, outpatient margin headwinds, and take-private update—read now.
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2025, its 2026 business outlook, and ...
StockStory.org on MSN
Select Medical’s (NYSE:SEM) Q4 CY2025: Beats on revenue
Healthcare services company Select Medical (NYSE:SEM) reported Q4 CY2025 results , with sales up 6.4% year on year to $1.40 ...
Meridian’s Regency Hospital is slated to close next month, hospital officials said Wednesday. Shelly Eckenroth, chief communication officer for Select Medical, which operates Regency Hospitals, said ...
Select Medical Corporation ("Select Medical") today announced it will own and operate a 12-bed rehabilitative neuro transitional center (NTC) located at 3705 Elmwood Drive, Harrisburg, PA 17110. This ...
Four research analysts have assigned buy ratings to the stock while one has issued a hold rating, with the average twelve-month price target at $17.80, implying roughly 12.7% upside from the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results